AU2002249486A1 - Macromolecular compounds as potential anti-inflammatory agents - Google Patents
Macromolecular compounds as potential anti-inflammatory agentsInfo
- Publication number
- AU2002249486A1 AU2002249486A1 AU2002249486A AU2002249486A AU2002249486A1 AU 2002249486 A1 AU2002249486 A1 AU 2002249486A1 AU 2002249486 A AU2002249486 A AU 2002249486A AU 2002249486 A AU2002249486 A AU 2002249486A AU 2002249486 A1 AU2002249486 A1 AU 2002249486A1
- Authority
- AU
- Australia
- Prior art keywords
- inflammatory agents
- potential anti
- macromolecular compounds
- macromolecular
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nanotechnology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2002/000689 WO2003080121A1 (en) | 2002-03-26 | 2002-03-26 | Macromolecular compounds as potential anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002249486A1 true AU2002249486A1 (en) | 2003-10-08 |
Family
ID=28053138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002249486A Abandoned AU2002249486A1 (en) | 2002-03-26 | 2002-03-26 | Macromolecular compounds as potential anti-inflammatory agents |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002249486A1 (en) |
| WO (1) | WO2003080121A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003275954A1 (en) * | 2002-11-08 | 2004-06-07 | Danmarks Fodevareforskning | Preparation of chemically well-defined carbohydrate dendrimer conjugates |
| US8658148B2 (en) | 2007-06-22 | 2014-02-25 | Genzyme Corporation | Chemically modified dendrimers |
| CA2701291A1 (en) | 2007-10-05 | 2009-04-09 | Wayne State University | Dendrimers for sustained release of compounds |
| WO2010013086A1 (en) * | 2008-08-01 | 2010-02-04 | Centre National De La Recherche Scientifique | Phosphorylated dendrimers as antiinflammatory drugs |
| US10106565B2 (en) | 2008-08-01 | 2018-10-23 | Centre National De La Recherche Scientifique | Phosphorylated dendrimers as antiinflammatory drugs |
| JP6302091B2 (en) | 2014-04-30 | 2018-03-28 | ザ・ジョンズ・ホプキンス・ユニバーシティー | Dendrimer composition and use thereof in the treatment of eye diseases |
| US10918720B2 (en) | 2014-08-13 | 2021-02-16 | The Johns Hopkins University | Selective dendrimer delivery to brain tumors |
| WO2021113662A2 (en) | 2019-12-04 | 2021-06-10 | Ashvattha Therapeutics, Inc. | Dendrimer compositions and methods for drug delivery to the eye |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPM623994A0 (en) * | 1994-06-15 | 1994-07-07 | Biomolecular Research Institute Limited | Antiviral dendrimers |
| EP0831817B1 (en) * | 1995-06-07 | 2001-03-14 | Joel K. Swadesh | Antigen-processing cell-targeted conjugates comprising a polyamino acid backbone and a non-steroidal anti-inflammatory agent |
| WO1999042091A2 (en) * | 1998-02-19 | 1999-08-26 | Massachusetts Institute Of Technology | Use of polycations as endosomolytic agents |
| US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| US20040120979A1 (en) * | 2000-06-02 | 2004-06-24 | Roessler Blake J. | Delivery systems comprising biocompatible and bioerodable membranes |
-
2002
- 2002-03-26 WO PCT/IB2002/000689 patent/WO2003080121A1/en not_active Application Discontinuation
- 2002-03-26 AU AU2002249486A patent/AU2002249486A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003080121A1 (en) | 2003-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003224597A1 (en) | Organic compositions | |
| AU2003290734A1 (en) | Novel compounds as pharmaceutical agents | |
| AU2003266949A1 (en) | Compounds | |
| AU2003221098A1 (en) | Oligofluorenylene compounds | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| AU2003293843A1 (en) | Non-steroidal anti-inflammatory agents | |
| AU2003300056A1 (en) | Organic compositions | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2003259438A1 (en) | Di and trifluoro-triazolo-pyridines anti-inflammatory compounds | |
| AU2003220968A1 (en) | Anti-inflammatory agent | |
| AU2002950744A0 (en) | Composition | |
| AU2003281307A1 (en) | Solvent composition | |
| AU2003269904A1 (en) | Antigen-polymer compositions | |
| AU2003208411A1 (en) | Anti-glycolytic composition | |
| AU2002249486A1 (en) | Macromolecular compounds as potential anti-inflammatory agents | |
| AU2003216859A1 (en) | Amidoacetonitrile compounds | |
| AU2003289207A1 (en) | Anti-inflammatory agent | |
| AU2003282510A1 (en) | Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents | |
| AU2003291642A1 (en) | Pyrazoloazepine compounds as pharmaceutical agents | |
| AU2003245703A1 (en) | Piperazine derivatives as anti-inflammatory agents | |
| AU2003202905A1 (en) | Organic composition | |
| AU2003302320A1 (en) | Seterocyclic quinones as pharmaceutical agents | |
| AU2003216503A1 (en) | Stable pharmaceutical compositions | |
| AUPS044102A0 (en) | New compound | |
| AU2002951868A0 (en) | Compound i |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |